undamentalytics Newsletter

Hedge fund

Tang Capital Management LLC

13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1232621

Reported value
$2.2bn
96% in companies we cover
Positions we cover
38
Largest AUPH 10.1%
Copy, a year
+3.4%
S&P 500 +14.1%
Copy Sharpe ratio
0.26
S&P 500 0.78

How copying its 13F would have done

$10.0k$20.0k$40.0k 2013201520172019202120232025 $57.0k$15.5k
CopyS&P 500 $10,000 copying Tang Capital Management LLC's filed holdings in companies we cover from August 16, 2013, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −77.9% (S&P 500 −31.8%); beta 0.99; alpha −0.2% a year (t = −0.02); last 12 months +11.8% against +12.1%.

Reported value by quarter

Tang Capital Management LLC: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $200B $400B $600B $800B Reported value, 2013-06-30: $78.3M Reported value, 2013-09-30: $74.8M Reported value, 2013-12-31: $76.8M Reported value, 2014-03-31: $147M Reported value, 2014-06-30: $141.8M Reported value, 2014-09-30: $128.3M Reported value, 2014-12-31: $151.6M Reported value, 2015-03-31: $147.4M Reported value, 2015-06-30: $289.1M Reported value, 2015-09-30: $247.7M Reported value, 2015-12-31: $225.6M Reported value, 2016-03-31: $192.5M Reported value, 2016-06-30: $200.7M Reported value, 2016-09-30: $219.1M Reported value, 2016-12-31: $168.2M Reported value, 2017-03-31: $276.7M Reported value, 2017-06-30: $281.7M Reported value, 2017-09-30: $327.5M Reported value, 2017-12-31: $631.2M Reported value, 2018-03-31: $680.4M Reported value, 2018-06-30: $789M Reported value, 2018-09-30: $612.5M Reported value, 2018-12-31: $435.9M Reported value, 2019-03-31: $542.7M Reported value, 2019-06-30: $740M Reported value, 2019-09-30: $584.5M Reported value, 2019-12-31: $837M Reported value, 2020-03-31: $712.2M Reported value, 2020-06-30: $1B Reported value, 2020-09-30: $552.7M Reported value, 2020-12-31: $655M Reported value, 2021-03-31: $355.4M Reported value, 2021-06-30: $502.4M Reported value, 2021-09-30: $481.7M Reported value, 2021-12-31: $497.2M Reported value, 2022-03-31: $494.1M Reported value, 2022-06-30: $659M Reported value, 2022-09-30: $815.4M Reported value, 2022-12-31: $688.3B Reported value, 2023-03-31: $671.1M Reported value, 2023-06-30: $679.3M Reported value, 2023-09-30: $708.7M Reported value, 2023-12-31: $1.1B Reported value, 2024-03-31: $960.4M Reported value, 2024-06-30: $979M Reported value, 2024-09-30: $1.4B Reported value, 2024-12-31: $1.5B Reported value, 2025-03-31: $1.8B Reported value, 2025-06-30: $2B Reported value, 2025-09-30: $2.6B Reported value, 2025-12-31: $2B Reported value, 2026-03-31: $2B Reported value, 2026-06-30: $2.2B 2013-06-30 2016-03-31 2018-12-31 2021-09-30 2026-06-30 $2.2B
View chart data
Period Reported value
2013-06-30 $78.3M
2013-09-30 $74.8M
2013-12-31 $76.8M
2014-03-31 $147M
2014-06-30 $141.8M
2014-09-30 $128.3M
2014-12-31 $151.6M
2015-03-31 $147.4M
2015-06-30 $289.1M
2015-09-30 $247.7M
2015-12-31 $225.6M
2016-03-31 $192.5M
2016-06-30 $200.7M
2016-09-30 $219.1M
2016-12-31 $168.2M
2017-03-31 $276.7M
2017-06-30 $281.7M
2017-09-30 $327.5M
2017-12-31 $631.2M
2018-03-31 $680.4M
2018-06-30 $789M
2018-09-30 $612.5M
2018-12-31 $435.9M
2019-03-31 $542.7M
2019-06-30 $740M
2019-09-30 $584.5M
2019-12-31 $837M
2020-03-31 $712.2M
2020-06-30 $1B
2020-09-30 $552.7M
2020-12-31 $655M
2021-03-31 $355.4M
2021-06-30 $502.4M
2021-09-30 $481.7M
2021-12-31 $497.2M
2022-03-31 $494.1M
2022-06-30 $659M
2022-09-30 $815.4M
2022-12-31 $688.3B
2023-03-31 $671.1M
2023-06-30 $679.3M
2023-09-30 $708.7M
2023-12-31 $1.1B
2024-03-31 $960.4M
2024-06-30 $979M
2024-09-30 $1.4B
2024-12-31 $1.5B
2025-03-31 $1.8B
2025-06-30 $2B
2025-09-30 $2.6B
2025-12-31 $2B
2026-03-31 $2B
2026-06-30 $2.2B

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
AUPHAurinia Pharmaceuticals Inc.10.11%$221.4m13.04M+6.7% Added
SYRESpyre Therapeutics, Inc.7.67%$168.0m1.89M0.0%
MIRMMirum Pharmaceuticals, Inc.6.61%$144.7m1.24M0.0%
KNSAKiniksa Pharmaceuticals International, plc6.60%$144.5m2.26M0.0%
CELCCelcuity Inc.6.28%$137.5m1.31M+25.2% Added
CORTCorcept Therapeutics Inc5.96%$130.4m1.50M0.0%
PTCTPTC Therapeutics, Inc.5.59%$122.4m1.50M0.0%
LKFTLakefront Biotherapeutics NV5.18%$113.5m3.79M0.0%
CAPRCapricor Therapeutics, Inc.4.51%$98.7m4.10M+20.6% Added
TARSTarsus Pharmaceuticals, Inc.4.51%$98.7m1.57M+31.9% Added
ANABAnaptysbio, Inc4.10%$89.8m1.33M0.0%
IMCRImmunocore Holdings plc3.84%$84.1m2.65M0.0%
CMPSCompass Pathways plc3.23%$70.8m5.00M+24.9% Added
ANIPANI Pharmaceuticals Inc2.67%$58.6m707.5K0.0%
BNTXBiontech SE2.00%$43.7m470.0K0.0%
CMPXCompass Therapeutics, Inc.1.80%$39.4m17.99M+7.1% Added
PGENPrecigen, Inc.1.67%$36.6m6.42M0.0%
VRDNViridian Therapeutics, Inc.\de1.50%$32.9m1.79M0.0%
NVCTNuvectis Pharma, Inc.1.30%$28.5m1.55MNew
DNTHDianthus Therapeutics, Inc.1.18%$25.8m264.7K0.0%
FULCFulcrum Therapeutics, Inc.1.09%$23.9m6.52MNew
AVIRAtea Pharmaceuticals, Inc.1.02%$22.4m4.81M0.0%
CBIOCrescent Biopharma, Inc.0.95%$20.9m1.16M0.0%
NNDMNano Dimension Ltd.0.95%$20.7m14.29MNew
VKTXViking Therapeutics, Inc.0.89%$19.5m500.0K0.0%
NUVBNuvation Bio Inc.0.86%$18.7m3.30M+4.8% Added
IDYAIdeaya Biosciences, Inc.0.77%$16.8m450.0K0.0%
DERMJourney Medical Corp0.52%$11.4m1.61M0.0%
INSMInsmed Inc0.49%$10.7m100.0K−61.5% Reduced
STOKStoke Therapeutics, Inc.0.45%$9.8m300.0K−40.0% Reduced
PLRXPliant Therapeutics, Inc.0.32%$7.0m6.14M0.0%
BOLDBoundless Bio, Inc.0.29%$6.4m2.56MNew
PMVPPMV Pharmaceuticals, Inc.0.26%$5.7m4.25M0.0%
MRNAModerna0.16%$3.5m50.0K−50.0% Reduced
HRTXHeron Therapeutics, Inc.0.12%$2.7m6.25M0.0%
LENZLenz Therapeutics, Inc.0.12%$2.6m451.1K0.0%
ALTAltimmune, Inc.0.09%$2.0m666.0K0.0%
RCKTRocket Pharmaceuticals, Inc.0.02%$342,000100.0K0.0%
CompanyBought (value)Shares
NVCTNuvectis Pharma, Inc.$28.5m1.55M
CELCCelcuity Inc.$27.7m264.6K
TARSTarsus Pharmaceuticals, Inc.$23.9m379.6K
FULCFulcrum Therapeutics, Inc.$23.9m6.52M
NNDMNano Dimension Ltd.$20.7m14.29M
CAPRCapricor Therapeutics, Inc.$16.9m700.0K
CMPSCompass Pathways plc$14.1m997.8K
AUPHAurinia Pharmaceuticals Inc.$13.8m814.6K
BOLDBoundless Bio, Inc.$6.4m2.56M
CMPXCompass Therapeutics, Inc.$2.6m1.20M
NUVBNuvation Bio Inc.$852,000150.0K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
INSMInsmed Inc−$17.1m−160.0K
JANXJanux Therapeutics, Inc.−$7.0m−500.0K
STOKStoke Therapeutics, Inc.−$6.5m−200.0K
BIIBBiogen−$6.4m−35.0K
URGNUrogen Pharma Ltd.−$6.3m−350.0K
ARVNArvinas, Inc.−$5.7m−538.7K
MRNAModerna−$3.5m−50.0K
AGIOAgios Pharmaceuticals, Inc.−$3.4m−100.0K
ERASErasca, Inc.−$3.2m−200.0K
CHRSCoherus Oncology, Inc.−$3.2m−1.89M
NKTXNkarta, Inc.−$3.1m−1.48M
EOLSEvolus, Inc.−$2.0m−483.0K
ABEOAbeona Therapeutics Inc.−$1.8m−400.0K
FATEFate Therapeutics Inc−$1.4m−1.17M
NMRANeumora Therapeutics, Inc.−$857,762−439.9K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanyValue last quarterShares
JANXJanux Therapeutics, Inc.$7.0m500.0K
BIIBBiogen$6.4m35.0K
URGNUrogen Pharma Ltd.$6.3m350.0K
ARVNArvinas, Inc.$5.7m538.7K
AGIOAgios Pharmaceuticals, Inc.$3.4m100.0K
ERASErasca, Inc.$3.2m200.0K
CHRSCoherus Oncology, Inc.$3.2m1.89M
NKTXNkarta, Inc.$3.1m1.48M
EOLSEvolus, Inc.$2.0m483.0K
ABEOAbeona Therapeutics Inc.$1.8m400.0K
FATEFate Therapeutics Inc$1.4m1.17M
NMRANeumora Therapeutics, Inc.$857,762439.9K
LXRXLexicon Pharmaceuticals, Inc.$623,532399.7K
  • Health Care99.0%
  • Technology1.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestAugust 16, 2013 to November 2, 2026+3.4%+14.1%0.260.78−77.9%0.99
2018 onwardsJanuary 5, 2018 to November 2, 2026+0.2%+13.9%0.140.66−77.9%0.95
Last three yearsNovember 3, 2023 to November 2, 2026+25.3%+21.8%0.791.16−26.8%1.01
Last yearNovember 7, 2025 to November 2, 2026+13.9%+14.2%0.510.84−15.6%0.87

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.